CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease Red Cell Distribution Width in Patients with Diabetes and Myocardial Infarction: an analysis from the EXAMINE trial Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement Management of Myocardial Revascularization Failure: An Expert Consensus Document of the EAPCI The (R)Evolution of the CICU - Better for the Patient, Better for Education Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Pharmacotherapy in the Management of Anxiety and Pain During Acute Coronary Syndromes and the Risk of Developing Symptoms of Posttraumatic Stress Disorder Complete Revascularization with Multivessel PCI for Myocardial Infarction

Original ResearchVolume 13, Issue 10, May 2020

JOURNAL:JACC: Cardiovascular Interventions Article Link

Evaluation and Management of Nonculprit Lesions in STEMI

T Thim, NW van der Hoeven, C Musto et al. Keywords: CFR; FFR; iFR; nonculprit coronary lesions; STEMI

ABSTRACT

Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.